Xiao Ding

This inventor holds 15 USPTO granted patents and 32 published patent applications and 7 EPO patents, primarily in Drug Development. Top assignees: Insilico Medicine IP Limited, Glaxosmithkline Intellectual Property Development Limited, Nio Technology (Anhui) Co., Ltd.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao Ding. Retrieved from https://idiyas.com/inventor/xiao-ding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 32)

% Patents Active = 60.0

EPO Patents = 7 (Patent Applications = 44)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

9 out of 40

Insilico Medicine IP Limited

patents

5 out of 242

Glaxosmithkline Intellectual Property Development Limited

patents

1 out of 179

Nio Technology (Anhui) Co., Ltd.

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

KIF18A Inhibitors

PHD Inhibitors

LRRK2 Inhibitors

SARS-CoV-2 Inhibitors

Diacylglycerol Kinase

Prolyl Hydroxylase

Methionine Adenosyltransferase

Parkinson's Disease

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760036 - Inhibitors of KIF18A and uses thereof (2026-10-13),

2. 12427836 - Vehicle refrigerator control method, storage medium, and vehicle (2025-09-30),

3. 12209101 - Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof (2025-01-28),

4. 12103915 - TEAD inhibitors and methods of uses thereof (2024-10-01),

5. 12077538 - Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof (2024-09-03),

6. 12071443 - Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof (2024-08-27),

7. 11999713 - Methionine adenosyltransferase 2a (MAT2A) inhibitors and uses thereof (2024-06-04),

8. 11780854 - Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof (2023-10-10),

9. 11731987 - Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof (2023-08-22),

10. 11731944 - SARS-CoV-2 inhibitors for treating coronavirus infections (2023-08-22),

11. 10975081 - Substituted fused pyrazole compounds and their use as LRRK2 inhibitors (2021-04-13),

12. 10858367 - Compounds (2020-12-08),

13. 10618901 - LRRK2 inhibitors for the treatment of Parkinson's disease (2020-04-14),

14. 10087186 - Compounds as LRRK2 kinase inhibitors (2018-10-02),

15. 9815841 - Compounds (2017-11-14),

Title: Innovations and Contributions of Inventor Xiao Ding

Introduction

Xiao Ding is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of electric vehicles and pharmaceuticals, holding a total of 14 patents. His innovative work focuses on enhancing user experience and optimizing vehicle functionality.

Latest Patents

Xiao Ding's latest patents include a vehicle refrigerator control method, storage medium, and vehicle. This invention addresses the challenges of intelligent identification of items stored in a vehicle refrigerator. It provides a method for controlling the refrigerator based on item information and vehicle state information. The method involves obtaining item information, real-time temperature, target temperature, and vehicle state information. By applying this method, users can quickly and accurately know the information of items stored in the vehicle refrigerator. It also allows for automatic setting of suitable target temperatures and controls the refrigerator to operate in different modes. This innovation not only optimizes control over the vehicle refrigerator but also addresses issues related to noise, vibration, harshness (NVH), and vehicle energy consumption, thereby enhancing user comfort.

Career Highlights

Xiao Ding has worked with notable companies such as Insilico Medicine IP Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions in both the automotive and pharmaceutical sectors.

Collaborations

Xiao Ding has collaborated with several professionals in his field, including Feng Ren and Yingxia Sang. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Xiao Ding's contributions to innovation, particularly in electric vehicles and pharmaceuticals, demonstrate his commitment to enhancing user experience and optimizing technology. His patents reflect a deep understanding of the challenges faced in these industries and provide effective solutions.

Profile summary based on public USPTO records.